P05960
Gene name |
gag-pol |
Protein name |
Gag-Pol polyprotein |
Names |
Pr160Gag-Pol |
Species |
Human immunodeficiency virus type 1 group M subtype B (isolate CDC-451) (HIV-1) |
KEGG Pathway |
|
EC number |
3.4.23.16: Aspartic endopeptidases |
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
0 structures for P05960
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|
No variants for P05960
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| No variants for P05960 | |||||
No associated diseases with P05960
8 regional properties for P05960
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | Immunodeficiency lentiviral matrix, N-terminal | 2 - 132 | IPR000071 |
| domain | Retroviral nucleocapsid Gag protein p24, N-terminal | 144 - 250 | IPR000721 |
| domain | Zinc finger, CCHC-type | 391 - 407 | IPR001878-1 |
| domain | Zinc finger, CCHC-type | 412 - 428 | IPR001878-2 |
| active_site | Aspartic peptidase, active site | 510 - 521 | IPR001969 |
| domain | Peptidase A2A, retrovirus, catalytic | 508 - 550 | IPR001995 |
| domain | Retropepsins | 494 - 549 | IPR018061 |
| domain | Retroviral nucleocapsid Gag protein p24, C-terminal domain | 277 - 349 | IPR045345 |
Functions
| Description | ||
|---|---|---|
| EC Number | 3.4.23.16 | Aspartic endopeptidases |
| Subcellular Localization |
|
|
| PANTHER Family | ||
| PANTHER Subfamily | ||
| PANTHER Protein Class | ||
| PANTHER Pathway Category | No pathway information available | |
6 GO annotations of cellular component
| Name | Definition |
|---|---|
| host cell nucleus | A membrane-bounded organelle as it is found in the host cell in which chromosomes are housed and replicated. The host is defined as the larger of the organisms involved in a symbiotic interaction. |
| host cell plasma membrane | The plasma membrane surrounding a host cell. |
| host multivesicular body | A late endosome in which regions of the limiting host cell endosomal membrane invaginate to form internal vesicles; host membrane proteins that enter the internal vesicles are sequestered from the host cytoplasm. |
| membrane | A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
| viral nucleocapsid | The complete protein-nucleic acid complex that is the packaged form of the genome in a virus particle. |
| virion membrane | The lipid bilayer surrounding a virion. |
5 GO annotations of molecular function
| Name | Definition |
|---|---|
| aspartic-type endopeptidase activity | Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a mechanism in which a water molecule bound by the side chains of aspartic residues at the active center acts as a nucleophile. |
| lipid binding | Binding to a lipid. |
| RNA binding | Binding to an RNA molecule or a portion thereof. |
| structural molecule activity | The action of a molecule that contributes to the structural integrity of a complex or its assembly within or outside a cell. |
| zinc ion binding | Binding to a zinc ion (Zn). |
2 GO annotations of biological process
| Name | Definition |
|---|---|
| proteolysis | The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds. |
| suppression by virus of host gene expression | Any process in which a virus stops, prevents, or reduces the frequency, rate or extent of gene expression in the host organism. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Some protein processing events may be included when they are required to form an active form of a product from an inactive precursor form. |
No homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| No homologous proteins | ||||
| 10 | 20 | 30 | 40 | 50 | 60 |
| MGARASVLSG | GELDRWEKIR | LRPGGKKQYR | LKHIVWASRK | LERFAVNPGL | LETSKGCRQI |
| 70 | 80 | 90 | 100 | 110 | 120 |
| LGQLQPSLQT | GSEELRSLYN | TVATLYCVHQ | RIEVRDTKEA | LDKIEEEQNK | SKKKAQQAAA |
| 130 | 140 | 150 | 160 | 170 | 180 |
| DTGNSSQVSQ | NYPIVQNLQG | QMVHQAISPR | TLNAWVKVIE | EKAFSPEVIP | MFAALSEGAT |
| 190 | 200 | 210 | 220 | 230 | 240 |
| PQDLNTMLNT | VGGHQAAMQM | LKETINEEAA | EWDRLHPVHA | GPIAPGQMRE | PRGSDIAGTT |
| 250 | 260 | 270 | 280 | 290 | 300 |
| STLQEQIGWM | TNNPPTPVGE | IYKRWIILGL | NKIVRMYSPI | SILDIRQGPK | EPFRDYVDRF |
| 310 | 320 | 330 | 340 | 350 | 360 |
| YKTLRAEQAS | QEVKNWMTET | LLVQNANPDC | KTILKALGPA | ATLEEMMTAC | QGVGGPGHKA |
| 370 | 380 | 390 | 400 | 410 | 420 |
| RVLAEAMSQV | TNSATIMMQR | GNFRRQGKTV | KCFNCGKEGH | IARNCKAPRK | KGCWKCGREG |
| 430 | 440 | 450 | 460 | 470 | 480 |
| HQMKDCTERQ | ANFLREDLAF | PQGKAREFSS | EQTRANSPTR | GELQVWGRDN | NSLSEAGAER |
| 490 | 500 | 510 | 520 | 530 | 540 |
| QGTVSFSFPQ | ITLWQRPIVT | IKIGGQLKEA | LLDTGADDTV | LEEINLPGRW | KPKMIGGIGG |
| FIKVRQYDEV |